High Blood Lipids Concern Everyone
Elevated blood lipids leading to cardiovascular diseases are the most common cause of death in Sweden and worldwide. Billions of people are waiting for new, more effective medications.
More about high blood lipids
”Our vision is to improve and extend the life of patients suffering from diseases related to high blood lipids”
Lipisense®
Lipisense® is Lipigon's most advanced project, currently in clinical trials. Through a unique mechanism of action, Lipisense® lowers triglycerides, a type of blood lipid that stands as a significant risk factor for cardiovascular disease. Today, at least five million patients in the seven major markets of the USA, Japan, Germany, France, Italy, Spain, and the United Kingdom suffer from significantly elevated blood lipids. Regrettably, only half of those treated with lipid-lowering drugs reach treatment goals.
About Lipisense®Lipigon – Half a Century of Blood Lipid Research
Our historySubscribe
Receive press releases and reports to your email directly as they are distributed.
Privacy policy